Medicine & TechnologyResults of a new study recently paved the way for an entirely new field of target treatments for people at risk of developing coronary heart disease which is considered the world's biggest killer.
A recent study has unveiled that the drug canagliflozin plays important role in treating the type 2 diabetes and simultaneously reduces the risk of the kidney problem and heart disease.